Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography.

Ali Tavakkolizadeh1, Urs V Berger, Antonia E Stephen

  • 1Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Transplantation
|January 28, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delivering living medicines with biomaterials.

Nature reviews. Materials·2026
Same author

Evaluation of a trauma center-based, technology enhanced stepped care intervention to promote the mental health recovery of adolescent traumatic injury survivors.

Contemporary clinical trials communications·2026
Same author

A human blood-brain barrier model reveals pericytes as critical regulators of viral neuroinvasion.

iScience·2026
Same author

Editor's Note: RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresistance.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Retraction: HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma.

Cancer research·2025
Same author

Retraction: Prostaglandin E2 Enhances Pancreatic Cancer Invasiveness through an Ets-1-Dependent Induction of Matrix Metalloproteinase-2.

Cancer research·2025

Tissue engineering created a prototype neointestine that successfully regenerated mucosal morphology and enterocyte dynamics after anastomosis to native bowel in rats, offering hope for short bowel syndrome treatment.

Area of Science:

  • Regenerative Medicine
  • Gastroenterology
  • Biomaterials Science

Background:

  • Short bowel syndrome (SBS) treatment relies on total parenteral nutrition, which has significant risks and costs.
  • Novel therapeutic strategies are crucial for managing SBS.
  • Tissue engineering offers a promising avenue for developing alternative treatments.

Purpose of the Study:

  • To develop and evaluate a prototype tissue-engineered neointestine.
  • To test the hypothesis that anastomosing the neointestine to native bowel promotes mucosal regeneration and restores enterocyte dynamics.

Main Methods:

  • Biodegradable polymers with neonatal rat intestinal organoids were used to create neointestinal cysts in rats.
  • Cyst-jejunal anastomoses were performed in a subset of rats.

Related Experiment Videos

  • Morphology, cell proliferation, apoptosis, and transporter expression were analyzed in native and neointestinal tissues.

    • Main Results:

    • Anastomosed neointestine (A-N) exhibited regenerated mucosal morphology and enterocyte proliferation patterns similar to native jejunum.
    • Transporter expression in A-N neointestine mimicked that of native jejunum.
    • Non-anastomosed neointestine (N-N) showed rudimentary development of these features.

    Conclusions:

    • Tissue-engineered neomucosa can achieve structural and functional characteristics of the native jejunum.
    • Anastomosis to the native intestine is critical for successful neomucosal development.
    • Tissue engineering presents a viable future therapeutic approach for SBS patients.